Cetuximab Activity in Dysplastic Lesions of the Upper Aerodigestive Tract

BACKGROUND: High risk head and neck mucosal premalignancy has a malignant conversion rate of up to 40%, despite adequate surgical therapy. Epidermal Growth Factor Receptor (EGFR) blocking agents, including cetuximab, have shown activity in head and neck squamous cell carcinoma (HNSCC) and have poten...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oral Oncol
Main Authors: Khan, Zubair, Epstein, Joel B, Marur, Shanthi, Gillespie, M Boyd, Feldman, Lawrence, Tsai, Hua-Ling, Zhang, Zhe, Wang, Hao, Sciubba, James, Ferris, Robert, Grandis, Jennifer R, Gibson, Michael, Koch, Wayne, Tufano, Ralph, Westra, William, Tsottles, Nancy, Ozawa, Hiroyuki, Chung, Christine, Califano, Joseph A
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7751887/
https://ncbi.nlm.nih.gov/pubmed/26686755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.oraloncology.2015.11.016
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki